Results 51 to 60 of about 80,877 (282)

Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids

open access: yesFrontiers in Public Health
Opioid-induced respiratory depression (OIRD) deaths are ~80,000 a year in the US and are a major public health issue. Approximately 90% of fatal opioid-related deaths are due to synthetic opioids such as fentanyl, most of which is illicitly manufactured ...
Albert Dahan   +8 more
semanticscholar   +1 more source

Police officer knowledge of and attitudes to opioid overdose and naloxone administration: an evaluation of police training in Scotland [PDF]

open access: yes
In the context of escalating drug-related deaths, during 2021 Police Scotland implemented a pilot project incorporating naloxone training to test the carriage and administration of naloxone by officers. The current paper presents data from the evaluation
Dougall, Nadine J.   +9 more
core   +2 more sources

Utilizing a train-the-trainer model for multi-site naloxone distribution programs [PDF]

open access: yes, 2016
BackgroundIn order to have a substantial impact on overdose prevention, the expansion and scaling-up of overdose prevention with naloxone distribution (OPEND) programs are needed.
Lobmaier, Philipp Paul   +3 more
core   +1 more source

Vital Signs: Pharmacy-Based Naloxone Dispensing — United States, 2012–2018

open access: yesMMWR. Morbidity and mortality weekly report, 2019
Background The CDC Guideline for Prescribing Opioids for Chronic Pain recommends considering prescribing naloxone when factors that increase risk for overdose are present (e.g., history of overdose or substance use disorder, opioid dosages ≥50 morphine ...
G. Guy   +5 more
semanticscholar   +1 more source

Naloxone for opioid overdose - Pharmacological aspects and dosing in clinical practice [PDF]

open access: yes, 2020
Dødsfall fra opioidoverdoser er et stort folkehelseproblem og utdeling av nesespray med motgiften nalokson var foreslått som et tiltak for å redde liv. I 2012 fantes det ingen godkjente nesesprayer på markedet. Istedenfor var improviserte, ikke-godkjente
Tylleskär, Ida Karin
core   +1 more source

Reasons People Who Use Opioids Do Not Accept or Carry No-Cost Naloxone: Qualitative Interview Study

open access: yesJMIR Formative Research, 2020
Background Many people use opioids and are at risk of overdose. Naloxone is an opioid antagonist used to counter the effects of opioid overdose. There is an increased availability of naloxone in New York City; however, many who use opioids decline no ...
Alex S. Bennett   +3 more
semanticscholar   +1 more source

Naloxone Access [PDF]

open access: yes, 2022
Key Points ● Naloxone is a life-saving opioid antagonist that can reverse an opioid overdose. Tennessee law makes it available to anyone with or without a prescription and protects from civil suit any physician who prescribes it, and any bystander who ...
Kourvelas, Jeremy   +2 more
core   +1 more source

SAFE – Home Opioid Management Education (SAFE-HOME) in older adults: a naloxone awareness program for home health workers

open access: yesDrugs in Context, 2021
Background: Older adults (≥65 years) have seen significant increases in opioid overdose deaths. Diversion of older adults’ opioid medication is also a contributor to opioid misuse.
Brianna M McQuade   +4 more
doaj   +1 more source

Identification of antibiotic allergies in children using prescribing patterns in the electronic medical record

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Background By age three, 5%–75% of children have a documented antibiotic allergy (AL). Despite this prevalence, recognition remains low because of limited clinician knowledge and time. Our study evaluates a novel approach to identifying AL using electronic medical record (EMR) prescription patterns.
Georgia Koutsaplis   +5 more
wiley   +1 more source

The effect of subcutaneous naloxone on experimentally induced pain [PDF]

open access: yes, 2008
The heat pain threshold was assessed in 32 healthy participants after a mild burn on the dorsal surface of each hand, after injection of an opioid antagonist (80 μg naloxone) or vehicle alone (0.2 mL saline) into the burnt skin of 1 hand, and after ...
Hammond, G.R.   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy